ABNORMAL PLASMINOGEN-PLASMIN SYSTEM ACTIVITY (FIBRINOLYSIS) IN PATIENTS WITH HEPATIC CIRRHOSIS: ITS CAUSE AND CONSEQUENCES.
D000410:Alanine Transaminase; D000469:Alkaline Phosphatase / Q000097:blood*; D001219:Aspartate Aminotransferases; D001706:Biopsy; D004796:Clinical Enzyme Tests; D004565:Electroconvulsive Therapy; D005341:Fibrinolysin; D005342:Fibrinolysis; D007456:Iodine Isotopes; D008103:Liver Cirrhosis; D008111:Liver Function Tests; D009525:Niacin; D009539:Nicotinic Acids; D010600:Pharmacology; D010958:Plasminogen; D011517:Prothrombin Time
D007456:Iodine Isotopes; D009539:Nicotinic Acids; D009525:Niacin; D010958:Plasminogen; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase; D005341:Fibrinolysin
ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIOPSY; BLOOD ALKALINE PHOSPHATASE; ENZYME TESTS; FIBRINOLYSIN; FIBRINOLYSIS; IODINE ISOTOPES; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; NICOTINIC ACID; PHARMACOLOGY; PLASMINOGEN; PROTHROMBIN TIME; SHOCK THERAPY, ELECTRIC